Scientists find a universal antibody therapy for all COVID-19 variants
In a new study from the University of Alabama at Birmingham, researchers discovered a monoclonal antibody that potentially acts as a potent universal coronavirus...
This new PCR test can detect all COVID-19 variants
In a new study from Rutgers University and elsewhere, researchers developed a PCR test that uses molecular beacons not only to diagnose COVID-19 infection,...
Fourth COVID vaccine shot for Omicron cannot benefit these people
In a new study from the Sheba Medical Center, researchers found the fourth dose of existing mRNA COVID-19 vaccines offer little benefit to younger...
This antiviral treatment is effective for COVID-19 new variants
In a new study from Rutgers, researchers found an antiviral drug used to treat SARS-CoV-2 remains effective against the newest variants of the evolving...
Has the page of COVID-19 finally turned? The pandemic’s psychological scars remain
It’s been a long and uncertain road, with some groups shouldering a disproportionately greater burden of mental anguish from COVID-19.
Yet now there’s a glimmer...
COVID-19 Delta breakthrough infection can strongly benefit these people
A new study from King's College London found a delta breakthrough infection generates a potent and broad neutralizing antibody response in double vaccinated individuals.
The...
Cognitive problems linked to higher death risk in COVID-19 pandemic
In a new study, researchers found that higher death rates are linked to the COVID-19 pandemic among older adults with cognitive impairment, like Alzheimer's...
‘Long COVID’ may lead to lingering airways disease, study finds
A new study from the University of Iowa found disease of the small airways in the lungs is a potential long-lasting effect of COVID-19.
They...
What’s behind post-COVID brain fog?
As a neurologist working in the COVID Survivorship Program at Beth Israel Deaconess Medical Center, I find that my patients all have similar issues.
It’s...
This drug may prevent severe COVID-19, new study finds
In a new study from the William Osler Health Centre, researchers found for people with mild-to-moderate COVID-19 and a high risk for progression, sotrovimab...